Merck KGaA

P&G: healthcare acquisition helps us stay on top of consumer 'megatrends'
P&G: healthcare acquisition helps us stay on top of consumer 'megatrends'
Medical Marketing and Media
Procter & Gamble
consumer health
Merck KGaA
Flag link:
Procter & Gamble Acquires Consumer Health Unit of Merck KGaA for $4.2B
Procter & Gamble Acquires Consumer Health Unit of Merck KGaA for $4.2B
CP Wire
Procter & Gamble
Merck KGaA
M&A
consumer health
Flag link:
Procter & Gamble Acquires Consumer Health Unit of Merck KGaA for $4.2B
Procter & Gamble
Merck KGaA
Flag link:
Merck KGaA Consumer Unit Is a Deal Too Far for Mylan: Gadfly
Merck KGaA Consumer Unit Is a Deal Too Far for Mylan: Gadfly
Washington Post, DC
Merck KGaA
consumer health
M&A
Mylan Labs
Flag link:
Mylan seeks deal for German Merck's consumer products unit - sources
Mylan seeks deal for German Merck's consumer products unit - sources
Yahoo/Reuters
Mylan Labs
Merck KGaA
consumer health
M&A
Flag link:
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
Endpoints
Eli Lilly
Merck KGaA
Btk inhibitors
autoimmune disease
evobrutinib
Flag link:
Face to face comparison Teva and Merck KGaA
Face to face comparison Teva and Merck KGaA
GoinPharma
Teva Pharmaceutical
Merck KGaA
Flag link:
Pfizer, Merck KGaA nab NICE's favor for Bavencio in Merkel cell carcinoma
Pfizer, Merck KGaA nab NICE's favor for Bavencio in Merkel cell carcinoma
Fierce Pharma
Pfizer
Merck KGaA
NICE
Bavencio
Merkel cell carcinoma
Flag link:
Merck KGaA injects $47M into Asian manufacturing efforts
Merck KGaA injects $47M into Asian manufacturing efforts
Biopharma Dive
Merck KGaA
drug manufacturing
Asia
India
South Korea
Flag link:
Merck KGaA to earn less than expected from sale of Consumer Health business
Merck KGaA to earn less than expected from sale of Consumer Health business
GoinPharma
Merck KGaA
consumer health
M&A
Flag link:
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
Endpoints
FDA
AstraZeneca
Imfinzi
lung cancer
Bavencio
Pfizer
Merck KGaA
Flag link:
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Yahoo/Reuters
Merck KGaA
Pfizer
lung cancer
Bavencio
clinical trials
Flag link:
Divestiture of Merck KGaA’s Consumer Health unit increasingly difficult
Divestiture of Merck KGaA’s Consumer Health unit increasingly difficult
GoinPharma
Merck KGaA
consumer healthcare
Flag link:
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Yahoo/Reuters
consumer health
M&A
Merck KGaA
Nestle
Flag link:
Pfizer defends kidney-cancer position with Bavencio 'breakthrough'
Pfizer defends kidney-cancer position with Bavencio 'breakthrough'
Fierce Pharma
Pfizer
kidney cancer
Bavencio
Merck KGaA
Flag link:
Array Biopharma ties up with Pfizer on cancer-fighting combos
Array Biopharma ties up with Pfizer on cancer-fighting combos
Fierce Biotech
Array Biopharma
Pfizer
clinical trials
binimetinib
talazoparib
Merck KGaA
Bavencio
cancer
Flag link:
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
GoinPharma
Nestle
Merck KGaA
M&A
consumer health
Flag link:
Pfizer, Merck KGaA run into a severe setback as PD-L1 drug Bavencio fails in PhIII gastric cancer study
Pfizer, Merck KGaA run into a severe setback as PD-L1 drug Bavencio fails in PhIII gastric cancer study
Endpoints
Pfizer
Merck KGaA
Bavencio
anti-PD-L1
gastric cancer
Flag link:
EMD Serono wins FDA nod for redesigned pen injector
EMD Serono wins FDA nod for redesigned pen injector
Drug Delivery Business News
EMD Serono
FDA
devices
Gonal-f RFF Redi-ject
Merck KGaA
Fertility
Flag link:
Shooting for a new standard on osteoarthritis, Merck KGaA outlines promising data for a potential game-changer
Shooting for a new standard on osteoarthritis, Merck KGaA outlines promising data for a potential game-changer
Endpoints
Merck KGaA
osteoarthritis
sprifermin
Merck Serono
Flag link:

Pages